| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a888a536389af4a49ebdc2c36de65848 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5412 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-70 |
| filingDate |
2020-05-07^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6980082206ac314df356e56bf222035e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5571bd4e8493a98177c1a098d03c6ade
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f38240997949f0a03a8471110b7c05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25c854a509f99e8192146d92f35b84f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478d811496830a62b2fbb89a4eee8022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d0f05f2106e678b8004b5d1c4399842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_725ab68d68c5c3c502a2835ab158704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8be4f9a1ab5bcd0ee27579c677fe5e5 |
| publicationDate |
2020-08-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020271670-A1 |
| titleOfInvention |
Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides |
| abstract |
The present description relates to a method for identifying a patient who is eligible for an intensification of heart failure therapy. Furthermore, the description relates to a method for pikej3optimizing B-type natriuretic peptide (BNP) and/or N-terminal pro B-type natriuretic peptide (NT-proBNP)-type peptide guided heart failure therapy. The methods are based on the measurement of the level of at least one marker in a sample from a patient who has heart failure and who receives B-type natriuretic peptide (BNP) and/or N-terminal pro B-type natriuretic peptide (NT-proBNP)-type peptide guided heart failure therapy. Further described are kits and devices adapted to carry out the described method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11143659-B2 |
| priorityDate |
2014-01-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |